• 1. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Excimer–monomer switch: a reaction-based approach for selective detection of fluoride?
  Qiao Song,Angela Bamesberger,Lingyun Yang,Haley Houtwed,Haishi Cao Analyst, 2014,139, 3588-3592
• 5. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

Dichloro-1,3-thiazole-5-carboxylic Acid (CAS No. 62019-56-1): A Key Intermediate in Modern Pharmaceutical Synthesis

Dichloro-1,3-thiazole-5-carboxylic acid, identified by the chemical identifier CAS No. 62019-56-1, is a significant intermediate in the realm of pharmaceutical chemistry. This compound, characterized by its dichloro-substituted thiazole core and a carboxylic acid functional group at the 5-position, has garnered considerable attention due to its versatile applications in the synthesis of bioactive molecules. The structural features of dichloro-1,3-thiazole-5-carboxylic acid make it a valuable scaffold for developing novel therapeutic agents, particularly in the areas of antimicrobial and anticancer research.

The thiazole ring, a heterocyclic structure containing sulfur and nitrogen atoms, is well-documented for its pharmacological properties. Compounds incorporating thiazole moieties have demonstrated efficacy across a spectrum of diseases, including infections and malignancies. The introduction of chlorine atoms at the 1 and 3 positions of the thiazole ring enhances the electrophilicity of the molecule, making it more reactive in various chemical transformations. This reactivity is particularly useful in medicinal chemistry for constructing complex drug molecules through nucleophilic aromatic substitution and other coupling reactions.

The carboxylic acid group at the 5-position of dichloro-1,3-thiazole-5-carboxylic acid provides an additional site for functionalization. This group can be readily converted into esters, amides, or other derivatives, further expanding the synthetic possibilities. Such modifications are often employed to improve solubility, bioavailability, and metabolic stability of drug candidates. In recent years, there has been a surge in research focused on developing small-molecule inhibitors targeting specific enzymes and receptors involved in disease pathways. Dichloro-1,3-thiazole-5-carboxylic acid has emerged as a key building block in these endeavors.

One of the most compelling applications of dichloro-1,3-thiazole-5-carboxylic acid is in the development of antimicrobial agents. The increasing prevalence of antibiotic-resistant bacteria has necessitated the discovery of novel antibiotics with unique mechanisms of action. Thiazole-based compounds have shown promise in this regard due to their ability to disrupt bacterial cell wall synthesis and other vital metabolic processes. For instance, studies have highlighted the potential of dichloro-thiazole derivatives as inhibitors of bacterial enzymes such as dihydrofolate reductase (DHFR), which is crucial for DNA synthesis in pathogens.

Furthermore, dichloro-1,3-thiazole-5-carboxylic acid has found utility in anticancer research. Cancer cells often exhibit altered metabolic pathways that can be exploited for therapeutic intervention. The thiazole scaffold has been incorporated into molecules designed to inhibit key enzymes involved in tumor metabolism, such as pyruvate kinase M2 (PKM2). By targeting these enzymes, thiazole-based compounds aim to disrupt energy production in cancer cells, thereby inhibiting their growth and proliferation. The carboxylic acid moiety allows for further derivatization to enhance binding affinity and selectivity towards cancer-specific targets.

The synthesis of dichloro-1,3-thiazole-5-carboxylic acid typically involves multi-step organic reactions starting from readily available precursors. A common synthetic route includes the chlorination of thiazole derivatives followed by carboxylation at the 5-position. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for industrial applications. Catalytic techniques and green chemistry principles have been increasingly employed to minimize waste and improve yields.

In conclusion, dichloro-1,3-thiazole-5-carboxylic acid (CAS No. 62019-56-1) represents a versatile intermediate with significant potential in pharmaceutical research and development. Its unique structural features facilitate the synthesis of diverse bioactive molecules targeting various diseases. As our understanding of disease mechanisms continues to evolve, compounds like dichloro-1,3-thiazole-5-carboxylic acid will remain indispensable tools for discovering new therapeutic agents that improve human health.

• 1015591-57-7(Methyl 4-chlorothiazole-5-carboxylate)
• 92972-48-0(2,4-dichloro-1,3-thiazole-5-carbaldehyde)
• 170232-69-6(2,4-Dichloro-5-thiazolemethanol)
• 125759-82-2(5-Thiazolecarboxylicacid, 2,4-dichloro-, ethyl ester)
• 101012-12-8(2-Chloro-1,3-thiazole-5-carboxylic Acid)
• 444909-59-5(4-chloro-1,3-thiazole-5-carboxylic acid)
• 444909-55-1(Ethyl 4-chlorothiazole-5-carboxylate)
• 861708-66-9(methyl 2,4-dichlorothiazole-5-carboxylate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)